Study infects volunteers with a malaria germ to test treatment
Part of Infections clinical trials.
This study gives healthy volunteers a controlled infection with a type of malaria (vivax) to see how the infection behaves and how well curative anti-malaria medicine works. It may help researchers better design and test future malaria vaccines and treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy Thai adult age 20 to 55 and weigh at least 50 kg
- Have blood that is “Duffy positive” (a specific blood marker)
- If you are female: use reliable birth control the whole study and for 3 months after the infection
- Have had at least two approved COVID-19 vaccine doses
- Be able to stay in Bangkok area and be monitored in the hospital until treatment finishes
- After infection, be willing to take the full anti-malaria cure and not donate blood during the study and for 1 year after treatment starts
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new malaria vaccine in healthy Thai adults. Participants will receive the vaccine and then be exposed to malaria in a controlled setting to see if the vaccine protects them. If you qualify, you'll be closely monitored and treated.
This study will expose healthy adults to a small number of mosquito bites carrying the P. vivax malaria parasite to learn how many bites are needed to cause infection. Participants will be closely monitored and treated in the hospital to ensure safety.
This trial tests a new malaria vaccine in healthy adults. It includes a controlled malaria infection to see how well the vaccine works. Participation lasts about a year with follow-up visits.
This study gives healthy adults who have never had malaria a controlled infection with the parasite that causes malaria, to see if it is safe and if mosquitoes can pick up the parasite from them. It may help develop new ways to prevent malaria.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Hear when a new Plasmodium Vivax Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.